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Abstract
Background: Serous carcinoma arising in adenomyosis and adenomyotic cyst is very rare. Only 3 serous carcinomas
and 5 serous endometrial intraepithelial carcinomas (EIC) have been reported to date.
Methods: We reviewed the clinicopathological features of 2 serous carcinoma in uterine adenomyosis and 1 serous
EIC in adenomyotic cyst of the cervical stump.
Results: Case 1 had an endometrial serous carcinoma in the uterine myometrium and the left ovary. A minor
component of benign endometrial glands with minimal endometrial stroma was found in the uterine mass
and the surrounding myometrium. Case 2 showed 3 small foci of serous carcinoma, serous EIC and endometrial
glandular dysplasia (EmGD) in the adenomyosis. Scanty serous carcinoma was present in the endometrium without
evidence of myometrial invasion. The eutopic endometrium in both case 1 and 2 had no evidence of neoplastic
changes after complete examination. Case 3 had 3 microscopic serous EICs in the adenomyotic cysts of the
cervical stump. One EIC lesion coexisted with EmGD. No cancer was found in the endocervical tube although
the preoperative endocervical biopsy showed a poorly differentiated endometrioid carcinoma. Immunohistochemistry
demonstrated that serous carcinoma in case 1 and EIC in all 3 cases showed a characteristic pattern of p53 and p16
over expression, high Ki67 index, and lack of WT1, ER and PR staining. EmGD in case 1 and 3 had a similar staining
pattern except a lower Ki67 index and the presence of ER expression.
Conclusions: We believe that this case series may expand our recognition on serous carcinoma arising in uterine
adenomyosis/adenomyotic cyst including extra-uterine spread and the potential synchronous growth of carcinomas in
eutopic endometrium.
Keywords: Endometrial serous carcinoma, Serous intraepithelial carcinoma, Endometrial glandular dysplasia,
Adenomyosis, Adenomyotic cyst, Immunohistochemistry
Background
Carcinomatous changes from the ectopic endometrial
glands in endometriosis have been reported in many
studies [1–4]. Most cases occur in patients with ovarian
endometriosis. Malignant transformation from uterine
adenomyosis is very unusual. Less than 50 cases have
been reported currently although the first case was
reported in 1897. The predominant histotypes of
these cases are endometrioid carcinoma and clear cell
carcinoma [4–6]. Serous carcinoma arising in uterine
adenomyosis is extremely rare. Only 3 reports con-
taining 3 serous carcinomas and 5 serous endometrial
intraepithelial carcinomas (EIC) have been reported to
date [7–10]. In this study, we present 2 serous carcin-
omas in uterine adenomyosis and 1 serous EIC in
adenomyotic cyst of the cervical stump.
Methods
The 3 cases reported here were retrieved from the ar-
chives of the Department of Surgical Pathology, the
Affiliated Women’s Hospital School of Medicine Zhejiang
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University, China, in the last 5 years. Patients 1 and 2 were
recent cases. We obtained clinical details and follow-up
data from hospital medical records. This study was ap-
proved by the Institutional Research Ethics Committee
of the Affiliated Women’s Hospital School of Medicine
Zhejiang University, China. The patients were well in-
formed and consent with this study. Archival routine
hematoxylin and eosin stained slides were assessed by
the authors.
Additional 4 μm sections were cut for immunohisto-
chemistry. The sources and dilutions of a group of anti-
bodies are detailed in Table 1. A two-step En Vision
immunostaining procedure (DAKO, Carpentaria, CA,
USA) was performed according to the manufacturer’s
protocols. The percentage of positive cells was scored as
follows: − for no immunoreactivity; focally + for 1 % to
5 %; + for 6 % to 25 %; ++ for 26 % to 50 %; +++ for
51 % to 75 %; ++++ for 76 % to 100 %. Over expression
of p16 and p53 were defined at least “+++”.
Results
Clinical findings
Table 2 summarizes the major clinical features of all 3
cases.
Case 1
A 64-year-old Chinese woman, gravida 2, para 2, com-
plained of left low abdominal pain for about 6 months.
Her last menses was more than 10 years ago. She denied
history of hormone replacement therapy. She had a his-
tory of diabetes mellitus with the treatment of Diamicron
and Metformin Hydrochloride for more than 10 years.
She denied familial history of cancer. Pelvic examination
revealed a slightly enlarged and symmetrical uterus. A
pelvic sonogram showed that the endometrium strip
measured 0.2 mm. An irregular mass of 2.5 × 2.6 ×
2.6 cm was present in the left parametrium. A cystic
lesion of 4.0 × 2.1 × 3.2 cm was found in the left
adnexus. It was adjacent to the mass in the left para-
metirum. The serum levels of CA125, CA 199 and
CA153 were normal. The clinical impression of this
case was “adenomyosis and possible left fallopian
tube-ovarian cyst”. Total abdominal hysterectomy and
bilateral salpingo-oophorectmy (TAHBSO) was ini-
tially performed. A 4.0-cm cystic lesion was found in
the left adnexus. The cystic lesion enveloped the left
ovary and fallopian tube, and adhered with the uterus
and intestine. However, the left ovary and fallopian
tube was not clearly seen. The uterus and the right
fallopian tube looked normal anatomically. After a
diagnosis of “adenocarcinoma in the left adnexus” was
rendered on frozen sections, a complete staging sur-
gery including retroperitoneal lymph node dissection
and omentectomy was subsequently carried out. A
small focus of endometriosis from the rectal adventi-
tia was also biopsied. The patient was given one
course of TP (Taxol + Carboplatin) chemotherapy and
was unremarkable for one month after surgery at
present.
Case 2
A 55-year-old Chinese woman gravida 1, para 1,
complained of postmenopausal vagina bleeding for
8 months. Uterine adenomyosis and multiple leiomyo-
mas were found 19 years ago. She was regularly
followed-up thereafter. Her serum CA199 was slightly
elevated (89.8 IU/mL) 4 months ago. Serum CA125
was normal. Recent pelvic sonogram indicated that the
enlarged uterus had a size similar to that of 2 weeks of
gestation and the endometrium strip measured
0.22 cm. There were multiple leiomyomas in the uterus.
The largest one measured 5.6 × 5.5 × 5.2 cm. Pelvic CT
scan and MRI had similar findings to that of sonogram.
Her medical history was significant for diabetes mellitus,
primary hypertension, asthma, appendectomy and caesar-
ean. The diagnosis of preoperative endometrial curetting
was serous carcinoma. TAHBSO and complete staging
surgery was performed 4 weeks after the diagnosis. One
course of adjuvant chemotherapy (TP) was given postop-
eratively by now.
Case 3
A 55-year-old Chinese woman, gravida 2, para 1, com-
plained of vaginal bleeding for 22 days. She had under-
gone a subtotal hysterectomy for uterine adenomyosis
Table 1 Antibody clones, sources, and dilutions
Antibody Clones Dilutions Sources
ER 1D5 1:300 Thermo
PR 1A6 1:500 Thermo
CK7 OV-TL 1:100 Thermo
CK20 KS20.8 1:100 Leica
PAX8 ZR1 1:50 Invitrogen
WT1 6 F-H2 1:150 Zeta
CA125 EPR1020(2) 1:50 Zeta
p53 DO-7 1:600 Thermo
CD10 56C6 1:100 Leica
D2-40 D2-40 1:400 Thermo
p16 16P04/JC2 1:100 Zeta
PTEN 17A 1:50 Zymed
β-catenin E247 1:400 Zymed
HNF1β C-20 1:200 Santa Cruz
Ki67 MIB-1 1:400 DAKO
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16 years ago. Sonogram revealed a 4.4 × 4.4 × 3.0 cm
mass in the cervical stump and a 3.3 × 3.5 × 2.8 cm cyst
in the left ovary. Pelvic CT scan showed an enlarged cer-
vical stump with a 2.5 × 1.7 × 1.5 cm mass and a 2.8 ×
2.4 × 3 cm cyst in the left ovary. The pathological
diagnosis of her endocervical curetting was poorly dif-
ferentiated endometrioid carcinoma. Her familial his-
tory was unremarkable except that her father died of
lung cancer. Radical resection of the cervical stump,
bilateral salpingo-oophorectmy (BSO) and complete
staging surgery were performed two weeks later. The
rectum was partially removed due to the presence of
endometriosis resulting in its dense adhesion with the
cervix stump. She was alive with no evidence of can-
cer for at least 44 months.
Pathological findings
The main pathological and immunohistochmical find-
ings of these cases are given in Table 3 and Table 4,
respectively.
Case 1
The uterus measured 6.5 × 3 × 3 cm. A 2.2 × 2.3 × 2.0-cm
mass was found in the outer two third of the uterine
myometrium. It extended from the left side of the cor-
pus to the isthmus. The mass had a white and coarsely
trabeculated cutting surface. The texture was similar to
that of the surrounding myometrium. The boundary of
the mass was not very clear. The myometrium surround-
ing the mass had foci of hemorrhage. A leiomyoma with
a diameter of 0.5 cm was found in the isthmus. The
endometrium was atrophic and about 0.1 cm thick. The
uterine cervix was unremarkable. The specimens from
the left adnexa (n = 4), the right fallopian tube (n = 2),
the uterine mass, the endometrium (n = 9) and the
cervix (n = 8) were all extensively sectioned for histo-
pathological examination.
The broken specimens from the left adnexus measured
4 × 3 × 2 cm. The fallopian fimbriae and ovary was
grossly unrecognizable, but the fallopian tube was par-
tially recognizable with a diameter of 1.0 cm. The tubal
Table 2 Clinical findings of the lesions
Case 1 Case 2 Case 3
Age (yr) 64 55 55
History of pregnancy G2P2 G1P1 G2P1
History of cancer N N N
Familial history of cancer N N Her father died of lung cancer.
Clinical presentation Left low abdominal pain Postmenopausal vagina bleeding Vaginal bleeding
Serum tumor biomarkers Normal CA125, CA199 & CA153 CA199: 89.8 IU/mL; Normal CA125 ND
Imaging findings Endometrium 0.2 cm; A mass in
the left parametrium; A cyst in
the left adnexus
Endometrium 0.22 cm; Uterine
leiomyomas
A mass in the cervical stump and a cyst
in the left ovary
Treatment TAHBSO + complete staging
surgery
TAHBSO + complete staging surgery Radical resection of the cervical stump + BSO
+ complete staging surgery
Postoperative chemotherapy Y Y N
Status of follow-up (time) Recent case Recent case Alive with no evidence of cancer (44 months)
Abbreviations: N no, Y yes, ND not done, BSO bilateral salpingo-oophorectmy, TAHBSO total abdominal hysterectomy and bilateral salpingo-oophorectmy
Table 3 Pathological results of the lesions
Case 1 Case 2 Case 3
FIGO Stage IIIa Ia Ia
Gross uterine mass - - -
Pathological findings in the endometrium - SC EC (G2-3)
Myometrium invasion NA - -
Lymphovascular tumor emboli + + -
Findings in the adenomyosis/ endometriotic cyst SC Minimal SC; serous EIC; EmGD Serous EIC; EmGD
Other findings Spread to the left ovarian;
Uterine leiomyoma;
Endometriosis in the rectum.
Uterine leiomyoma Glandular cyst in the cervix stump;
Left ovarian endometriotic cyst;
Endometriosis in the rectum.
Abbreviations: SC serous carcinoma, EIC serous endometrial intraepithelial carcinoma, EmGD endometrial glandular dysplasia, EC endometrioid carcinoma, NA
not applicable
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wall measured 0.3-0.4 cm. Some cystic wall-like tissue
had a thickness of 0.1-0.2 cm. Two pieces of grey-to-
white, tender solid tissues, measured 1.5 × 1.0 × 0.8 cm
and 0.8 × 0.5 × 0.5 cm, separately, were present in the
broken tissues. The right fallopian tube and ovary, and
omentum were grossly normal.
Microscopically, the uterine mass showed neoplastic
glands splitting smooth muscle fibers (Fig. 1a). It displayed
an expansive growth pattern towards the surrounding
myometrium. The neoplastic glands were lined by
markedly atypical, cuboidal to columnar cells with
hyperchromasia, conspicuous nucleoli, and irregular
nuclear membrane and numerous mitotic figures
(>12/10HPFs) (Fig. 1b). The luminal borders were
smooth, and some had epithelial tufts. Small clusters of
atypical cells surrounded by a clear space were commonly
seen. However, desmoplastic stroma was inconspicuous.
A small amount of benign endometrial glands with min-
imal endometrial stroma were present in the adjacent
normal myometrium surrounding the tumor and within
the tumor, implicating the presence of adenomyosis
(Fig. 1a, c). Tumor emboli within the lymphovascular ves-
sels were occasionally found within the myometrium. The
atrophic endometrium showed resting changes without
neoplastic evidence including cancer precursor alter-
ations. The small nodule in the isthmus was a leiomyoma.
The solid tissues in the left adnexus showed the same
morphological changes as in the uterine mass in general
(Fig. 1d). However, they showed a vaguely multi-nodular
growth pattern with a prominent desmoplastic reaction.
There were no benign-looking endometrioid glands in
the tumor. Ovarian stroma was discernable at the per-
iphery of the lesion. The left fallopian tube and the cystic
wall were in keeping with hydrosalpinx and showed no
evidence of serous tubal intraepithelial carcinoma (STIC)
or serous carcinoma. Biopsy from the rectal adventitia
was diagnosed as endometriosis.
Tumors from the uterine and ovarian mass showed
an identical immunohistochemical profile (Table 4;
Fig. 1e-g). Notably, CD10 clearly demonstrated the
presence of endometrial stroma surrounding the benign
glands in the uterine tumor (Fig. 1h).
Case 2
The uterus measured 13 × 9 × 6.5 cm. There were
multiple leiomyomas in the myometrium. The largest
one had a diameter of 5.0 cm. Adenomyosis was dif-
fusely found in the myometrium. It was characterized
by the trabeculated cut surface and small foci of
hemorrhage. No gross tumor was identified in the
uterine cavity. The endometrium measured 0.1 cm
and looked unremarkable. The uterus including endo-
metrium and myometroum (n = 17) were completely
examined. The fallopian fimbriae (n = 2 for each side)
were also extensively investigated.
The preoperative endometrial curetting consisted of a
small amount of specimen (measured 0.3 × 0.3 × 0.2 cm)
with artifact crush. It showed a typical pattern of serous
carcinoma including the papillary structure with a slen-
der fibrous core and the highly atypical lining epithelial
cells. In the resected uterus, only a small amount of ser-
ous carcinoma was found in 3 foci (each with a diameter
Table 4 Immunostaining results of the lesionsa
Antibodies Case 1 Case 2 Case 3
Adenomyosis Left Ovary Curetting Adenomyosis Curetting Adenomyosis
ER - - - - - -
PR - - - - - -
CK7 +++ +++ ND ND ND ND
CK20 - - ND ND ND ND
PAX8 +++ +++ +++ +++ +++ +++
WT1 - - - - - -
CA125 ++ ++ ND ND ND ND
p53 +++ +++ +++ +++ +++ +++
CD10a - - ND ND ND ND
D2-40a - - - - ND ND
PTEN ++ ++ ++ ++ ND ND
β-catenin Mem+ Mem+ Mem+ Mem+ ND ND
p16 +++ +++ +++ +++ +++ +++
HNF1β ND ND - - - -
Ki67 >80 % >80 % >70 % >70 % >80 % >80 %
Abbreviations: ND not done, Mem membrane staining
aCD10 and D2-40 was used to highlight the presence of endometrial stroma and lymphovascular invasion in the adenomyosis, respectively
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of <0.5 mm) from 17 slides from the whole endomet-
rium with partial myometrium. They were all located
within the endometrium, and did not show evidence of
myometrial invasion. Serous EIC and Endometrial glan-
dular dysplasia (EmGD) was not found in the eutopic
endometrium. Three small foci of serous neoplasia
(2 mm-3 mm in diameters) were found from 2 of 12
slides from the region of adenomyosis. They were clearly
separated from the basalis of the endometrium. Two le-
sions showed a minimal serous carcinoma and a serous
EIC (Fig. 2a, 2g). The neoplastic cells showed significant
atypia including nuclear pleomorphism and prominent
nucleoli (Fig. 2b). The third lesion contained a predom-
inant component of EmGD (Fig. 2c) and a minor serous
EIC. All these lesions were surrounded by stromal cells.
Lymphovascular invasion was occasionally found in the
myometrium. Immunohistochemistry showed that both
SC in the endometrial curetting and SC/serous EIC in
the adenomyosis had the same immunostaining pattern
(Table 4). The neoplastic cells were diffusely positive for
p53 and Ki67, and negative for ER, PR and WT1
(Fig. 2h). The cells in EmGD showed an identical
Fig. 1 Serous carcinoma in uterine adenomyosis (case 1). The uterine mass showed neoplastic glands with marked atypia splitting smooth
muscle fibers a, b. A small amount of benign endometrial glands with minimal endometrial stroma were found at the periphery of the tumor
and within the tumor, implicating the presence of adenomyosis a, c: arrows. The identical morphological changes were seen in the left adnexus
d. Both uterine and ovarian tumors showed an identical immunohistochemical profile including p53 over expression e, high Ki67 index f, and
WT1 -ve g. CD10 staining highlights the presence of endometrial stroma surrounding the benign glands in the uterine tumor h. (Original
magnifications: A*25; B*400; C-G*200)
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staining pattern except for a moderate ER expression
and a relatively lower Ki67 index (approximately 40 %)
(Fig. 2d-f ).
Case 3
The cervical stump measured 5 × 5 × 4.5 cm. The mu-
cosa looked a little bit rough, but no tumor was grossly
seen in the cervical canal. A 3 × 1.5 × 1.5-cm mass was
recognizable in the myometrium. The mass had 3 small
cysts containing brownish, viscous fluid. The diameters
of these cysts varied between 0.5-1.0 cm. These cysts
were at least 7 mm from the endocervical surface. The
left ovarian cyst showed the similar gross features and
had a size of 4 × 3.5 × 3 cm. The resected rectum mea-
sured 5.5 cm long. The intestinal wall was partly scleros-
ing and hemorrhagic. The lumen became narrow, but
had no macroscopic tumors or polyps. The cervical
stump (n = 15) was extensively examined for microscopic
assessment.
The preoperative endocervical biopsy showed a pre-
dominantly solid pattern and a minor component of
glandular structures in keeping with a poorly differenti-
ated endometrioid carcinoma (grade 2–3). However, no
residual tumors were found in the removed cervical
stump. A 0.4-cm lesion of hemorrhage with abundant
hemosiderin-containing macrophages was noted at the
Fig. 2 Serous EIC in uterine adenomyosis (case 2). A small focus of serous carcinoma and serous EIC (arrows) was present in the adenomyosis
a. The neoplastic cells showed significant atypia b. The pattern of endometrial glandular dysplasia (EmGD) was shown in another field c. Higher
magnification (original magnification *400) showed the presence of nuclear atypia in EmGD (inserted in the left lower corner of c). The cells in
EmGD showed p53 over expression d, a relatively lower Ki67 index (approximately 40 %) e, and a moderate ER expression (++) f. The neoplastic
cells in serous carcinoma and EIC (arrows) were diffusely positive for p53 g. (Original magnifications: A*50; B-G*200)
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surface of the cervical mucosa. Three microscopic foci
of serous EIC (each 1 mm in diameter) were noted in 2
of 3 adenomyotic cysts in the cervical stump. They had
a slightly papillary contour with fibrous cores and the
cells displayed hobnail cellular morphology and signifi-
cant atypia (Fig. 3a, b). A focus of EmGD was seen in
the adjacent area of one serous EIC lesion (Fig. 3e, f ).
Endometriosis was present in 4 slides from the sur-
rounding cervical myometrium and parametrium. The
left ovarian lesion was an endometriotic cyst. The rectal
serosa and muscularis propria were significant for endo-
metriosis. The immunostaining results of carcinoma in
the endocervical biopsy and serous EIC in the adeno-
myotic cyst was shown in Table 4 (Fig. 3g, h). The
EmGD lesion had an expression pattern identical to
serous EIC except the lower Ki67 index (30 %) and
patchy p16 staining (Fig. 3e, f ).
Discussion
Carcinoma arising from adenomyosis was initially re-
ported more than one century ago. Sampson or Colman’s
criteria for the diagnosis of carcinoma arising from adeno-
myosis were proposed early in 1950s [11, 12]. These in-
cludes: “1) the carcinoma must not be present in the
normally situated endometrium or elsewhere in the pelvis;
b) the carcinoma must be seen to arise from the epithe-
lium within the adenomyosis rather than invasion from
another source; and c) endometrial (adenomyotic) stromal
cells must be seen to support a diagnosis of adenomyosis”.
In fact, these criteria appear to be too stringent. In
Fig. 3 Serous EIC in adenomyotic cyst of the cervical stump (case 3). Serous EIC was present in the adenomyotic cysts by showing a slightly
papillary contour with fibrous cores and the cells displayed hobnail cellular morphology and significant atypia a, b. The serous EIC showed p53
over expression c and a high Ki67 index d. A focus of EmGD and serous EIC (arrow) was seen in the adjacent area of one serous EIC lesion e, f.
The EmGD lesion showed p53 over expression g and a relatively lower Ki67 index h. (Original magnifications: A, E*50; C, D*100; B, F-H*200)
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previous reports, 3 of 5 serous EICs and 1 of 4 car-
cinomas could not be classified as true tumors arising
in adenomyosis if all 3 criteria should fully be satis-
fied [8, 9]. However, the authors provided compelling
evidence to support that their cases should be consid-
ered as originating from adenomyosis.
In this study, we also understand that our cases do not
meet the Sampson or Colman’s criteria completely, but
we think that they are most likely from adenomyosis as
we discuss below. The point most contradictory to the
criteria in case 1 is the coexistence of uterine and ovar-
ian carcinoma with the identical morphological and im-
munostaining features. The question arises that both
carcinomas are primary or one is metastatic from the
other. However, we believe that the ovarian lesion is un-
likely to be primary according to the following findings.
First, the ovarian carcinoma was grossly unapparent
while the uterine carcinoma was obvious. The uterine
tumor was deeply located in the myometrium. It had a
relatively clear boundary and grossly looked like an ade-
nomyoma (adenomyosis). Moreover, there was no tumor
in the pelvis beyond the left ovary and uterus. In particu-
lar, serous carcinoma and its precursor lesions were not
seen in the endometrium and cervix even after an exten-
sive microscopic inspection on these sites. Second, the
ovarian carcinoma was characterized by overwhelmingly
glandular structures with severe cytological atypia, but
no papillary formation was seen. The great disagreement
of structure (G1) and nuclear grading (G3) is a classical
diagnostic clue for endometrial serous carcinoma [13]. A
diffuse glandular pattern is not a common feature for
ovarian serous carcinoma. Moreover, no STIC and ovar-
ian endometriosis was found in both fallopian tubes and
ovaries. The frequency of STICs was 61 % in pelvic high
grade serous carcinoma [14]. Endometriotic cyst can be
an uncommon source of ovarian or pelvic serous carcin-
oma [2, 15, 16]. In contrast, the uterine carcinoma
showed a pattern of neoplastic glands intermingled with
smooth muscles, architecturally resembling an adeno-
myoma. Endometriosis was found in the tumor and the
surrounding myometrium. Third, both uterine and ovar-
ian cancers were totally negative for WT1 and ER, and
had p53 over expression and a high Ki67 index. It was
well documented that WT1 and ER expression was com-
monly present in ovarian serous carcinomas with a fre-
quency of approximately 90 %, and very unusual in
endometrial serous carcinoma [17–19]. Therefore, the
WT1-ve and ER -ve pattern in both tumors of this case
indicated that serous carcinoma in the uterine myome-
trium was most likely primary from adenomyosis, which
had largely been replaced by tumor overgrowth. Accord-
ingly, the ovarian carcinoma was secondary from the dir-
ect extension or lymphovascular spread of carcinoma in
the uterine adenomyosis.
The presence of carcinoma in the endometrial cav-
ity (case 2) and endocervical tube (case 3) may throw
doubt on the origin of the endometriotic carcinoma
from adenomyosis. We think that these cases can be
explained by synchronous growth of endometrial and
endometriotic carcinomas as reported previously [8].
In case 2, adenomyosis was diffuse and mostly was
uninvolved by the serous cancer cells. The 3 involved
foci of adenomyosis were separated clearly from the
basalis of the endometrium while the small endomet-
rial carcinoma was completely limited within the
endometrium. In case 3, there was no residue tumor
at the surface of the endocervix in the surgical speci-
mens. The histotypes were different between the ori-
ginal endocervical biopsy and the lesions in the
cervical adenomyosis. These lesions in the adenomyo-
tic cyst were at least 7 mm from the endocervical
surface. Moreover, all these microscopic lesions in the
myometrium from case 2 and case 3 were clearly sur-
rounded by benign stromal cells. They had foci of
EmGD and serous EIC. Serous EIC is the established
precursor lesion of endometrial serous carcinoma
while EmGD is an emerging early lesion preceding
EIC [20–22]. Kumar et al. [23] also emphasized that
the presence of either a transition or continuity be-
tween the benign adenomyotic endometrial glands
and the carcinomatous glands was essential to prove
the adenomyotic origin of the carcinoma and to ex-
clude the possibility of metastasis or invasion from
elsewhere. The coexistence of EmGD and EIC in our
cases indicates the interrelationships between the ec-
topic endometrium and serous carcinoma, thus makes
metastasis from the eutopic endometrium most unlikely.
Two additional points in our cases deserved further
discussion. Lymphovascular invasion is uncommon in
EIC although EIC can spread in the peritoneum [24].
However, the distinction of extensive EIC and early
invasive serous carcinoma has not been well estab-
lished. According to the criteria suggested by Dr
Wheeler DT, et al. [25], serous carcinoma in the
endometrium and adenomyosis from case 2 may both
represent for a minimally invasive serous carcinoma
and can cause lymphovascular invasion. However, we
think that the lymphovascular invasion is most likely
associated with serous carcinoma from adenomyosis
because it is present in the myometrium. Moreover,
the endometrial serous carcinoma did not show evi-
dence of myometrial invasion. In case 3, the presence
of hobnail cell changes in EIC showed overlapping
features with minute clear cell carcinoma or clear cell
carcinoma in situ. However, such hobnail cellular
changes can also be present in EIC [26]. HNF1β and
Napsin A are typically expressed by clear cell carcin-
oma [27, 28], but they are completely negative in this
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case (data not shown). Taken the presence of EmGD
together, our case is regarded as EIC most likely.
Two broad categories, type I and II, endometrial car-
cinomas have been well documented [29]. On the basis
of these two categories, a “dualistic model” of endomet-
rial carcinogenesis has been developed recently with
the accumulative clinical, morphological and molecular
evidence [30]. The prototype of type I carcinoma is
endometrial carcinoma, which is associated with un-
opposed estrogen stimulus, and favorable prognosis.
Serous carcinoma is the prototype of type II carcinoma.
It is unrelated to the effect of unopposed estrogen. It
invariably harbors p53 mutation and has poor progno-
sis. The type I carcinoma is much more common than
type II carcinoma in the uterine endometrium. Carcin-
oma from ectopic endometrium is not very uncommon,
and most in ovarian endometriosis. The ovarian carcin-
oma associated with endometriosis predominantly rep-
resents for endometrioid and clear cell types [4–6]. In
the less than 50 well documented carcinomas arising
from adenomyosis, only three were serous carcinoma
or serous papillary carcinoma [7–10]. These data sug-
gest that carcinomas arising from the ectopic endomet-
rium including adenomyosis are predominantly type I
over type II. Our report not only adds new cases to this
rare carcinoma arising from adenomyosis, but also pro-
vides a characteristic immunostaining profile (PTEN+,
ER-, membranous β-catenin+, p53 and p16 over expres-
sion, high Ki67 index) to uncover the distinct molecular
alterations in type II carcinoma. Abushahin et al. [8]
proved the presence of p53 mutation in 1 of 5 serous
EICs arising in adenomyosis. That study also inferred
that EmGD and serous EIC, arising in adenomyosis
may be underdiagnosed because of their small foci in
adenomyosis. In favor of their opinion, we observed
that serous carcinomas in adenomyosis may also be
under-recognized particularly when carcinoma occurred
simultaneously in the endometrium or outside the uterus.
Carcinomas of the cervical stump after subtotal
hysterectomy are not uncommon with an incidence
of 0.1-3 %. Among these carcinomas, approximately
88 % were squamous cell carcinoma and the
remaining were adenocarcinoma [31, 32]. However,
we could not find any reports on adenocarcinoma or
serous EIC arising in endometriosis (adenomyotic
cyst) of the cervical stump in English literature to
date. Case 3 demonstrated the presence of serous
EIC in adenomyotic cyst in the cervical stump fol-
lowing the subtotal hysterectomy for adenomyosis.
Gynecologists might take this rare complication into
account in addition to the preservation of possible
physiologic and sexual functions of the cervix when
they decided to perform a proper surgery for women
with diffuse uterine adenomyosis.
Conclusions
In summary, our cases present a rare phenomenon
that serous carcinoma and EIC can arise from ectopic
endometrium including uterine adenomyosis and ade-
nomyotic cyst in the cervical stump. Their small size
as well as their inconspicuous histological features
under scanning magnification may cause these lesions
to be overlooked. Such cases may potentially become
the unrecognizable source of extra-uterine or pelvic
spread. These cases highlight the necessity of regular
clinical follow up in patients with untreated uterine
adenomyosis or subtotal hysterectomy for adenomyo-
sis, and more meticulous pathological inspection on
the resected uterine specimens. However, more stud-
ies are necessary to investigate the epidemiology and
pathogenesis in serous carcinoma and EIC arising
from ectopic endometrium, and to develop reliable
approaches to delineate these cases from benign le-
sions preoperatively.
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